Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$26.24 - $39.63 $429,994 - $649,416
16,387 New
16,387 $644,000
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $4.16 Million - $8.63 Million
456,631 Added 49.1%
1,386,542 $13.3 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $16.83 $4.35 Million - $6.03 Million
-358,005 Reduced 27.8%
929,911 $15.7 Million
Q4 2021

Feb 14, 2022

SELL
$13.83 - $18.78 $3.3 Million - $4.48 Million
-238,310 Reduced 15.61%
1,287,916 $21.5 Million
Q3 2021

Nov 15, 2021

BUY
$7.07 - $17.5 $8.7 Million - $21.5 Million
1,230,217 Added 415.6%
1,526,226 $24.8 Million
Q2 2021

Aug 16, 2021

BUY
$5.69 - $7.17 $618,303 - $779,128
108,665 Added 58.0%
296,009 $1.87 Million
Q1 2021

May 17, 2021

BUY
$5.08 - $6.89 $897,905 - $1.22 Million
176,753 Added 1668.9%
187,344 $1.16 Million
Q4 2020

Feb 16, 2021

BUY
$5.65 - $7.66 $59,839 - $81,127
10,591 New
10,591 $73,000
Q3 2020

Nov 16, 2020

SELL
$4.01 - $6.29 $134,214 - $210,526
-33,470 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.06 - $6.6 $498,122 - $1.07 Million
-162,785 Reduced 82.95%
33,470 $171,000
Q1 2020

May 15, 2020

BUY
$2.83 - $8.44 $555,401 - $1.66 Million
196,255 New
196,255 $675,000
Q4 2019

Feb 14, 2020

SELL
$0.93 - $8.58 $110,024 - $1.02 Million
-118,306 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$1.09 - $1.29 $22,925 - $27,132
-21,033 Reduced 15.09%
118,306 $133,000
Q2 2019

Aug 14, 2019

BUY
$1.21 - $1.48 $168,600 - $206,221
139,339 New
139,339 $181,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.